Skip to content

Using Digital Data to Predict CHD

Using Digital Data to Predict Cardiovascular Health and Health Care Utilization

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04574882
Enrollment
781
Registered
2020-10-05
Start date
2020-09-25
Completion date
2025-06-01
Last updated
2025-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases

Keywords

digital data, digital health

Brief summary

This project seeks to identify and characterize features derived from digital data (e.g. social media, online search, mobile media) which are associated with coronary heart disease (CHD) and related risk factors, and develop models that use digital data and conventional predictive models to predict CHD risk and health care utilization.

Detailed description

Cardiovascular disease is the leading cause of death in the US. While secondary prevention approaches have improved longevity of patients, risk factors and adverse health behaviors (e.g., physical inactivity, smoking) are highly prevalent, and in most contemporary series, less than 1% of adults meet all factors of ideal CV health. The logistics and practicalities of meeting the goal of ideal CV health have not been clearly elucidated. Practice guidelines recommend using the Framingham risk score (FRS) or other risk prediction tools to classify patients' risk of CV disease. These models however are imprecise and there is increasing focus on identifying markers that provide better measures of risk. As digital platforms are increasingly used to document lifestyle and health behaviors, data from digital sources may provide a window into manifestations of novel risk factors and potentially a better characterization of existing risk factors. While it seems like a cliche to mention the profound impact of digital data on everyday lives, there is indeed great substance in the opportunities these new media provide for understanding behavioral, social, and environmental determinants of health. This project seeks to identify and characterize features derived from digital data (e.g. social media, online search, mobile media) which are associated with coronary heart disease (CHD) and related risk factors, and develop models that use digital data and conventional predictive models to predict CHD risk and health care utilization.

Interventions

OTHERSurvey

Interested participants may complete the informed consent online. After informed consent, the participant will be asked to share the digital data types that they use (Facebook, Instagram, Twitter, Google search, step data) and then participants will complete a cross-sectional survey.

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
30 Years to 74 Years
Healthy volunteers
Yes

Inclusion criteria

* 30 - 74 years of age * Willing to sign informed consent * Primarily English speaking (for language analysis) * Has an account on any of the following digital data platforms (Facebook, Instagram, Twitter Reddit, Google (gmail), or smartphone or wearable device such as Apple Health, Fitbit, Samsung Health, MapMyFitness or Garmin) and willing to share data * If has social media account, Instagram or Facebook, willing to share historical and prospective data (60 days) If has Google (gmail) account, willing to download and share google takeout zip file * If has smartphone or wearable device, willing to share step data * Willing to share access to medical health records * Willing to share healthcare insurance information

Exclusion criteria

* Patient does not meet age inclusion criteria above * Does not use and post on digital data sources we are studying or unwilling to donate data * Patient is in severe distress, e.g. respiratory, physical, or emotional distress * Patient is intoxicated, unconscious, or unable to appropriately respond to questions

Design outcomes

Primary

MeasureTime frameDescription
Latent Dirichlet Allocation (LDA) Topics - Topics / Themes Discussed Between Patients With and Without Heart DiseaseThrough study completion, an average of 3 yearsThe primary outcome is topics and features (derived using the LDA method for clustering language data). For each participant, we included all available Facebook wall posts from the start of their account history through data collection, regardless of whether they occurred before or after a CHD diagnosis. We examined associations between linguistic features (unigrams, LIWC categories, LDA topics) and cardiovascular case status (CHD presence vs absence) using Pearson correlation and logistic regression. Latent LDA, a systematic method to identify text-based themes, was applied to generate 200 clusters of co-occurring words (topics). For each feature type (unigram, LIWC category, LDA topic), we fit separate logistic regression models and calculated Pearson correlation coefficients to assess predictive value for case status. Each language-derived feature was encoded as a normalized frequency count per user to enable consistent comparison across participants.

Other

MeasureTime frameDescription
CHD EventThrough study completion, an average of 3 yearsReliability in predicting CHD related event in patient as measured by Framingham Risk Score. The Framingham Risk Score (FRS) is a validated means of predicting cardiovascular disease (CVD) risk. Input variables include age, cigarette smoking, total cholesterol, HDL cholesterol, systolic blood pressure measurement and treatment for hypertension. Point values are calculated based on each of these risks. A 10-year risk score can be derived as a percentage. Risk scores range from 0-20%. Low Risk: Less than 10% risk that you will develop a heart attack or die from coronary disease in the next 10 years. Intermediate risk: A 10 to 20% risk that you will develop a heart attack or die from coronary disease in the next 10 years. High Risk: A greater than 20% risk that you will develop a heart attack or die from coronary disease in the next 10 years.
Health Care UtilizationThrough study completion, an average of 3 yearsPrediction of cost for health care utilization between heart disease and non- heart disease subjects measured by insurance claims data

Countries

United States

Participant flow

Participants by arm

ArmCount
Case
Patients ages 30-74 with and without CHD (IICD 10: I63, I20-I25 ) within the last 5 years. Survey: Interested participants may complete the informed consent online. After informed consent, the participant will be asked to share the digital data types that they use (Facebook, Instagram, Twitter, Google search, step data) and then participants will complete a cross-sectional survey.
326
Control
Patients aged 30-74 who have non-cardiovascular-related history Survey: Interested participants may complete the informed consent online. After informed consent, the participant will be asked to share the digital data types that they use (Facebook, Instagram, Twitter, Google search, step data) and then participants will complete a cross-sectional survey.
455
Total781

Baseline characteristics

CharacteristicControlTotalCase
Age, Continuous59.5 years
STANDARD_DEVIATION 9.2
60.1 years
STANDARD_DEVIATION 9.8
60.1 years
STANDARD_DEVIATION 9.5
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Asian
13 Participants23 Participants10 Participants
Race (NIH/OMB)
Black or African American
152 Participants207 Participants55 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
35 Participants78 Participants43 Participants
Race (NIH/OMB)
White
254 Participants471 Participants217 Participants
Sex: Female, Male
Female
287 Participants428 Participants141 Participants
Sex: Female, Male
Male
125 Participants272 Participants147 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Latent Dirichlet Allocation (LDA) Topics - Topics / Themes Discussed Between Patients With and Without Heart Disease

The primary outcome is topics and features (derived using the LDA method for clustering language data). For each participant, we included all available Facebook wall posts from the start of their account history through data collection, regardless of whether they occurred before or after a CHD diagnosis. We examined associations between linguistic features (unigrams, LIWC categories, LDA topics) and cardiovascular case status (CHD presence vs absence) using Pearson correlation and logistic regression. Latent LDA, a systematic method to identify text-based themes, was applied to generate 200 clusters of co-occurring words (topics). For each feature type (unigram, LIWC category, LDA topic), we fit separate logistic regression models and calculated Pearson correlation coefficients to assess predictive value for case status. Each language-derived feature was encoded as a normalized frequency count per user to enable consistent comparison across participants.

Time frame: Through study completion, an average of 3 years

Population: To evaluate predictive performance for ASCVD risk, we used regression and classification analyses. Pearson correlations assessed how language features predicted continuous risk scores. For classification, we measured AUC for binary risk (≥10% vs \<10%) and standard risk categories. Three logistic regression models were tested: language alone, demographics alone, and combined. Arms/groups were combined because the goal was to predict ASCVD risk continuously and categorically across participants.

ArmMeasureGroupValue (NUMBER)
Binary Classification (≥10% vs. <10%) Binary ClassificationLatent Dirichlet Allocation (LDA) Topics - Topics / Themes Discussed Between Patients With and Without Heart DiseaseUnigrams only0.61 proportion probability AUC (Area Under t
Binary Classification (≥10% vs. <10%) Binary ClassificationLatent Dirichlet Allocation (LDA) Topics - Topics / Themes Discussed Between Patients With and Without Heart DiseaseLIWC + Demographics (age, sex, race)0.79 proportion probability AUC (Area Under t
Binary Classification (≥10% vs. <10%) Binary ClassificationLatent Dirichlet Allocation (LDA) Topics - Topics / Themes Discussed Between Patients With and Without Heart DiseaseLIWC only0.55 proportion probability AUC (Area Under t
Binary Classification (≥10% vs. <10%) Binary ClassificationLatent Dirichlet Allocation (LDA) Topics - Topics / Themes Discussed Between Patients With and Without Heart DiseaseUnigrams + Demographics (age, sex, race)0.61 proportion probability AUC (Area Under t
Binary Classification (≥10% vs. <10%) Binary ClassificationLatent Dirichlet Allocation (LDA) Topics - Topics / Themes Discussed Between Patients With and Without Heart DiseaseLDA only0.64 proportion probability AUC (Area Under t
Binary Classification (≥10% vs. <10%) Binary ClassificationLatent Dirichlet Allocation (LDA) Topics - Topics / Themes Discussed Between Patients With and Without Heart DiseaseLDA + Demographics (age, sex, race)0.81 proportion probability AUC (Area Under t
Binary Classification (≥10% vs. <10%) Binary ClassificationLatent Dirichlet Allocation (LDA) Topics - Topics / Themes Discussed Between Patients With and Without Heart DiseaseDemographics only0.85 proportion probability AUC (Area Under t
All Risk CategoriesLatent Dirichlet Allocation (LDA) Topics - Topics / Themes Discussed Between Patients With and Without Heart DiseaseLDA + Demographics (age, sex, race)0.82 proportion probability AUC (Area Under t
All Risk CategoriesLatent Dirichlet Allocation (LDA) Topics - Topics / Themes Discussed Between Patients With and Without Heart DiseaseDemographics only0.87 proportion probability AUC (Area Under t
All Risk CategoriesLatent Dirichlet Allocation (LDA) Topics - Topics / Themes Discussed Between Patients With and Without Heart DiseaseLIWC only0.67 proportion probability AUC (Area Under t
All Risk CategoriesLatent Dirichlet Allocation (LDA) Topics - Topics / Themes Discussed Between Patients With and Without Heart DiseaseUnigrams only0.71 proportion probability AUC (Area Under t
All Risk CategoriesLatent Dirichlet Allocation (LDA) Topics - Topics / Themes Discussed Between Patients With and Without Heart DiseaseLDA only0.67 proportion probability AUC (Area Under t
All Risk CategoriesLatent Dirichlet Allocation (LDA) Topics - Topics / Themes Discussed Between Patients With and Without Heart DiseaseLIWC + Demographics (age, sex, race)0.80 proportion probability AUC (Area Under t
All Risk CategoriesLatent Dirichlet Allocation (LDA) Topics - Topics / Themes Discussed Between Patients With and Without Heart DiseaseUnigrams + Demographics (age, sex, race)0.74 proportion probability AUC (Area Under t
Other Pre-specified

CHD Event

Reliability in predicting CHD related event in patient as measured by Framingham Risk Score. The Framingham Risk Score (FRS) is a validated means of predicting cardiovascular disease (CVD) risk. Input variables include age, cigarette smoking, total cholesterol, HDL cholesterol, systolic blood pressure measurement and treatment for hypertension. Point values are calculated based on each of these risks. A 10-year risk score can be derived as a percentage. Risk scores range from 0-20%. Low Risk: Less than 10% risk that you will develop a heart attack or die from coronary disease in the next 10 years. Intermediate risk: A 10 to 20% risk that you will develop a heart attack or die from coronary disease in the next 10 years. High Risk: A greater than 20% risk that you will develop a heart attack or die from coronary disease in the next 10 years.

Time frame: Through study completion, an average of 3 years

Other Pre-specified

Health Care Utilization

Prediction of cost for health care utilization between heart disease and non- heart disease subjects measured by insurance claims data

Time frame: Through study completion, an average of 3 years

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026